Literature DB >> 17082678

Pregnancy-associated changes in the hemostatic system.

Charles J Lockwood1.   

Abstract

Pregnancy, from implantation to parturition, presents unique and profound challenges to a women's hemostatic system. During pregnancy, potentially catastrophic bleeding can occur during implantation and endovascular trophoblast invasion of the maternal spiral arteries. The risk of hemorrhage reaches a peak during the third stage of labor when the placenta is shorn from the decidua basalis exposing 120 spiral arteries largely denuded of their smooth muscle, and thus, their ability to constrict in response to injury. These challenges are met by dramatic changes in the local uterine, and systemic hemostatic systems. The net effect of these changes is to increase the efficiency of clotting and to impair fibrinolysis. Unfortunately, they also lead to an increase in the prevalence of venous thromboembolism, which is otherwise uncommon in reproductive age women.

Entities:  

Mesh:

Year:  2006        PMID: 17082678     DOI: 10.1097/01.grf.0000211952.82206.16

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  14 in total

Review 1.  Recurrent miscarriage, antiphospholipid antibodies and the risk of thromboembolic disease.

Authors:  M Ángeles Martínez-Zamora; Ricard Cervera; Juan Balasch
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

Review 2.  Nonclinical aspects of venous thrombosis in pregnancy.

Authors:  Evi Struble; Wafa Harrouk; Albert DeFelice; Belay Tesfamariam
Journal:  Birth Defects Res C Embryo Today       Date:  2015-09-25

Review 3.  Novel insights into molecular mechanisms of abruption-induced preterm birth.

Authors:  Catalin S Buhimschi; Frederik Schatz; Graciela Krikun; Irina A Buhimschi; Charles J Lockwood
Journal:  Expert Rev Mol Med       Date:  2010-11-01       Impact factor: 5.600

4.  Platelets contain tissue factor pathway inhibitor-2 derived from megakaryocytes and inhibits fibrinolysis.

Authors:  Kanagasabai Vadivel; Sathya-Moorthy Ponnuraj; Yogesh Kumar; Anne K Zaiss; Matthew W Bunce; Rodney M Camire; Ling Wu; Denis Evseenko; Harvey R Herschman; Madhu S Bajaj; S Paul Bajaj
Journal:  J Biol Chem       Date:  2014-09-28       Impact factor: 5.157

5.  First-trimester bleeding characteristics associate with increased risk of preterm birth: data from a prospective pregnancy cohort.

Authors:  D R Velez Edwards; D D Baird; R Hasan; D A Savitz; K E Hartmann
Journal:  Hum Reprod       Date:  2011-11-03       Impact factor: 6.918

Review 6.  DIC in Pregnancy - Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments.

Authors:  Offer Erez; Maha Othman; Anat Rabinovich; Elad Leron; Francesca Gotsch; Jecko Thachil
Journal:  J Blood Med       Date:  2022-01-06

7.  NTPDase and 5'-nucleotidase activities in platelets of human pregnants with a normal or high risk for thrombosis.

Authors:  Claudio A M Leal; Maria R C Schetinger; Daniela B R Leal; Karine Bauchspiess; Clarissa M L Schrekker; Paula A Maldonado; Vera M Morsch; José E P da Silva
Journal:  Mol Cell Biochem       Date:  2007-06-08       Impact factor: 3.396

Review 8.  [Hemorrhaging during pregnancy].

Authors:  S Hofer; R Schreckenberger; B Heindl; K Görlinger; H Lier; H Maul; E Martin; M A Weigand
Journal:  Anaesthesist       Date:  2007-10       Impact factor: 1.041

Review 9.  An integrated systems biology approach to the study of preterm birth using "-omic" technology--a guideline for research.

Authors:  Sara Gracie; Craig Pennell; Gunvor Ekman-Ordeberg; Stephen Lye; James McManaman; Scott Williams; Lyle Palmer; Maureen Kelley; Ram Menon; Michael Gravett
Journal:  BMC Pregnancy Childbirth       Date:  2011-10-12       Impact factor: 3.007

10.  Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis.

Authors:  Justin Cuff; Keyan Salari; Nicole Clarke; Ghada E Esheba; Andrew D Forster; Stephanie Huang; Robert B West; John P Higgins; Teri A Longacre; Jonathan R Pollack
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.